RIVERSEDGE ADVISORS, LLC

Position in EXEL — Exelixis, Inc.

CIK 1787663 Wilmington, DE

Position in EXEL

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$204,527

New position

Shares Held

3,759

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#583

of 751 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

RIVERSEDGE ADVISORS, LLC holds $1,173,687 across 4 Biotechnology names. EXEL ranks #4 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	993	$493,252
2	REGN	Regeneron Pharmaceuticals, Inc.	390	$243,180
3	INCY	Incyte Corp	2,053	$232,728
4	EXEL	Exelixis, Inc. This page	3,759	$204,527

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$204,527	3,759	—	Shares	Sole	2026-07-16
No filing history on record for this holder in this stock.